This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA  Social Bookmarking   What's this?

JAMA. 2002;287:2593-2994.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Physicians in the United States, Canada, and Mexico

Physicians with current and valid licenses in the United States, Canada, or Mexico who read any 3 of the selected continuing medical education (CME) articles in this issue of JAMA, complete the CME Evaluation Form, and fax it to the number or mail it to the address at the bottom of the CME Evaluation Form are eligible for category 1 CME credit. There is no charge.

The American Medical Association (AMA) is accredited by the Accreditation Council for Continuing Medical Education to sponsor CME for physicians. The AMA designates this educational activity for up to 1 hour of category 1 CME credit per JAMA issue toward the AMA Physician's Recognition Award (PRA). Each physician should claim for credit only those hours that were actually spent in this educational activity.

Physicians in Other Countries
Physicians with current and valid licenses in the United States, Mexico, or Canada are eligible for . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLES

Predictors of Acute Complications in Children With Type 1 Diabetes
Arleta Rewers, H. Peter Chase, Todd Mackenzie, Philip Walravens, Mark Roback, Marian Rewers, Richard F. Hamman, and Georgeanna Klingensmith
JAMA. 2002;287(19):2511-2518.
ABSTRACT | FULL TEXT  

Ethnic Disparities in Diabetic Complications in an Insured Population
Andrew J. Karter, Assiamira Ferrara, Jennifer Y. Liu, Howard H. Moffet, Lynn M. Ackerson, and Joe V. Selby
JAMA. 2002;287(19):2519-2527.
ABSTRACT | FULL TEXT  

Cost-effectiveness of Intensive Glycemic Control, Intensified Hypertension Control, and Serum Cholesterol Level Reduction for Type 2 Diabetes
The CDC Diabetes Cost-effectiveness Group
JAMA. 2002;287(19):2542-2551.
ABSTRACT | FULL TEXT  

Effect of Therapeutic Footwear on Foot Reulceration in Patients With Diabetes: A Randomized Controlled Trial
Gayle E. Reiber, Douglas G. Smith, Carolyn Wallace, Katrina Sullivan, Shane Hayes, Christy Vath, Matthew L. Maciejewski, Onchee Yu, Patrick J. Heagerty, and Joseph LeMaster
JAMA. 2002;287(19):2552-2558.
ABSTRACT | FULL TEXT  

Effects of Moderate Alcohol Intake on Fasting Insulin and Glucose Concentrations and Insulin Sensitivity in Postmenopausal Women: A Randomized Controlled Trial
Michael J. Davies, David J. Baer, Joseph T. Judd, Ellen D. Brown, William S. Campbell, and Philip R. Taylor
JAMA. 2002;287(19):2559-2562.
ABSTRACT | FULL TEXT  

Effect of Intensive Therapy on the Microvascular Complications of Type 1 Diabetes Mellitus
The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group
JAMA. 2002;287(19):2563-2569.
ABSTRACT | FULL TEXT  

Diabetes and Atherosclerosis: Epidemiology, Pathophysiology, and Management
Joshua A. Beckman, Mark A. Creager, and Peter Libby
JAMA. 2002;287(19):2570-2581.
ABSTRACT | FULL TEXT